1/38
Looks like no tags are added yet.
what does ctDNA stand for?
circulating tumour DNA
NIH definition of a biomarker
biomarkers are any … than can be objectively … and evaluated as an indicator of a … … process, … process or … response to a … intervention
characteristics, measured, normal biological, pathogenic, pharmacologic, therapeutic
NCI definition of a biomarker
a biological … found in the …, … … or … that is a sign of a … or … process or of a condition or …
molecule, blood, body fluids or tissues, normal or abnormal, disease
4 main types of molecular biomarkers
DNA
RNA
proteins
metabolites
4 main types of characteristics acting as biomarkers
molecular
histologic
radiographic
physiologic
roles of biomarkers
… disease
… disease
predict …
determine …
monitor treatment …
monitor … and …
detect
stage
response to treatment
treatment efficacy
compliance
progression and recurrance
units of measurement for cancer biomarkers in the blood
ng/dL
cancer biomarkers based on criteria other than biomolecules
imaging biomarkers
pathological biomarkers
in silico biomarkers
what biomarker is commonly elevated in prostate cancer?
prostate specific antigen (PSA)
what is the most common EGFR mutation causing TKI resistance in NSCLC?
T790M
what does NSCLC stand for?
non small cell lung cancer
an ideal biomarker should be measured … and … using an assay with high analytical … and …
easily and reliably, sensitivity and specificity

does the left arrow show a false positive or negative?
false negative

does the right arrow show a false positive or negative?
false positive
first biochemical test for the detection of cancer
in 1847 … discovered a … protein in the urine of a … … patient where it was present in large … and was revealed by simple heat …
Bence Jones, globulin, multiple myeloma, quantities, denaturation
Bence-Jones protein (BJP) is a … produced free … … chain ( aka a …)
tumour, immunoglobulin light chain, paraprotein
in which body fluids is BJP found?
urine and serum
2 types of ulta-sensitive technologies
next generation sequencing and digital droplet PCR
next generation sequencing (NGS)
technology for determining the sequence of … and … to study … …
it enables the sequencing of … DNA strands at the same time
NGS achieves more … results with … amounts of sample
… … testing has enabled therapy decision based on genetic …
DNA and RNA, genetic variation
many
sensitive, smaller
gene panel, variants
digital droplet PCR (ddPCR)
method that provides absolute … of nucleic acids without needing a … curve
improves the … of qPCR and enables the detection of rare mutations such as … in a population of … type sequences
single PCR sample is partitioned into … droplets
each droplet undergoes PCR … and analysis separately
the droplets are the individually … and … as positive or negative for …
quantification, standard
sensitivity, SNVs, wild
20,000
amplification
counted and scored, fluorescence
BRCA1 and BRCA2 gene mutations indicate risk for which 2 types of cancers?
breast and ovarian
… mutations in the … tumour suppressor gene causes … cancer
loss of function, APC, colorectal
mutations in the … and … mismatch repair genes lead to … … … cancer
MLH1 and MLH2, hereditary nonpolyposis colorectal
mutations in the … protooncogene accounts for 95% of … … … cancer cases
RET, hereditary medullary thyroid
cancer screening tests for the following types of cancer
cervical
breast
colorectal
prostate
ovarian
PAP and HPV
mammography
FOB and sigmoidoscopy
PSA
CA125
… … … (CEA) is a … involved in cell … normally produced during … development but not present in the … of healthy adults
carcinogenic embryonic antigen, glycoprotein, adhesion, fetal, blood
elevated levels of CEA are commonly used as biomarkers for monitoring … and … cancer
colon and pancreatic
CA125 is a … used for tracking … to treatment, … after treatment and detecting … of … cancer
glycoprotein, response, prognosis, recurrance, ovarian
elevated CEA levels are associated with other … not just pancreatic and colorectal, making it an unreliable biomarker for … or early …
carcinomas, diagnosis, detection
increased serum concentration of CA125 have also been observed in relatively … conditions such as … and other malignant cancers besides ovarian
benign, endometriosis
utilisation of CA125 does not demonstrate the clinical … and … required for ovarian cancer …
sensitivity and specificity, screening
increased … PSA levels are indicative of … cancer
serum, prostate
majority of PSA in the blood is bound to … … only a small portion of … PSA is not
comparison of … PSA to … PSA is used to assess the risk of cancer as the ratio is … in cancer meaning the levels of … PSA increase
serum proteins, free
free, total, decreased, free
elevated levels of PSA can also be attributed to prostate …, … and … … …
ths tests for PSA do not show the … and … required for prostate cancer …
infection, irritation and benign prostatic hypertrophy
sensitivity and specificity, screening
CA19-9 is a … used to monitor … cancer patients’ … to treatment and help detect …
elevated levels of CA19-9 have also been correlated with other cancers as well as … conditions such as … and … …
thus this biomarker does not exhibit sufficient … and … to be used for pancreatic cancer …
glycoprotein, pancreatic, response, recurrance
nonmalignant, pancreatitis and cystic fibrosis
sensitivity and specificity, screening
… and … are epitopes of the same protein antigen product of the … gene
CA15-3 and CA27-29, MUC1
which gene codes for CA125?
MUC16
CA15-3 and CA27-29 are biomarkers for … cancer and a high … level typically indicates … breast cancer and a large … …
breast, CA15-3, advanced, tumour burden
due to Ca15-3’s lack of … and … it has only been approved for monitoring patients’ … to treatment and to help detect …
sensitivity and specificity, response, recurrance